Suppr超能文献

降压治疗对原发性高血压患者交感神经系统活性的影响。

Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.

作者信息

Chernow B, Zaloga G P, Lake C R, Coleman M D, Ziegler M G

出版信息

Fed Proc. 1984 Jan;43(1):72-7.

PMID:6317467
Abstract

The sympathetic nervous system (SNS) plays a major role in blood pressure regulation. Although the exact relationship of the SNS to the etiology of hypertension remains undetermined, many of the agents used to treat hypertension interfere with this system. Clonidine, methyldopa, guanethidine, and reserpine decrease SNS tone whereas hydralazine, minoxidil, and hydrochlorothiazide increase it. Most evidence suggests that beta-adrenergic blocking agents decrease SNS activity. The effect of prazosin and captopril on the SNS requires further study. The appropriate use of these antihypertensive agents requires a knowledge of their sites of action and the physiological reflexes they induce. Efficacy, toxicity, and effective drug combinations can be predicted based on their mechanism of action and effect on SNS activity.

摘要

交感神经系统(SNS)在血压调节中起主要作用。尽管SNS与高血压病因的确切关系仍未确定,但许多用于治疗高血压的药物会干扰该系统。可乐定、甲基多巴、胍乙啶和利血平会降低SNS张力,而肼屈嗪、米诺地尔和氢氯噻嗪则会增加SNS张力。大多数证据表明,β-肾上腺素能阻滞剂会降低SNS活性。哌唑嗪和卡托普利对SNS的作用有待进一步研究。合理使用这些抗高血压药物需要了解它们的作用部位以及所引发的生理反射。基于它们的作用机制和对SNS活性的影响,可以预测疗效、毒性和有效的药物组合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验